Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation
Marco C. Pinho(The University of Texas Southwestern Medical Center), Elizabeth R. Gerstner(University of California, Los Angeles), Patrick Y. Wen(Dana-Farber Cancer Institute), A. Gregory Sorensen(eHealth Africa), Jayashree Kalpathy–Cramer(University of Colorado Denver), Tracy T. Batchelor(Brigham and Women's Hospital), Pavlina Polaskova(Harvard–MIT Division of Health Sciences and Technology), Bruce R. Rosen(Massachusetts General Hospital), Dominique Jennings(Harvard University), Kyrre E. Emblem(Oslo University Hospital)
Cited by 24
Related Papers
3D Slicer as an image computing platform for the Quantitative Imaging Network
|Magnetic Resonance Imaging|2012|9.1k
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k